Nuclear factor kappa B: important transcription factor and therapeutic target

Area of Science:

• Molecular Biology
• Immunology
• Pharmacology

Background:

• Nuclear factor kappa B (NF-kappa B) is a crucial transcription factor regulating immune and inflammatory responses.
• It controls the expression of genes encoding cytokines, chemokines, and other immune mediators.
• Dysregulation of NF-kappa B is implicated in diseases like rheumatoid arthritis and asthma.

Purpose of the Study:

• To review the role of NF-kappa B in immune and inflammatory processes.
• To summarize the mechanisms of NF-kappa B activation and inhibition.
• To highlight pharmacologic agents that target NF-kappa B pathways.

Main Methods:

• Literature review of NF-kappa B function and regulation.
• Analysis of known inhibitors targeting different steps of NF-kappa B activation.
• Discussion of therapeutic implications in immunologically mediated diseases.

Main Results:

• NF-kappa B activation involves cytoplasmic sequestration by I kappa B and nuclear translocation.
• Numerous pharmacologic agents inhibit NF-kappa B at various steps, including glucocorticoids, calcineurin inhibitors, deoxyspergualin, salicylates, and antioxidants.
• These inhibitors target different mechanisms such as I kappa B dissociation, calcineurin activity, nuclear translocation, and upstream signaling.

Conclusions:

• NF-kappa B is a central regulator of inflammation and immunity.
• Targeting NF-kappa B activation pathways offers a promising therapeutic approach for inflammatory and autoimmune diseases.
• Further development of specific NF-kappa B inhibitors is needed for effective disease treatment.